Skip to main content

Tango Therapeutics, Inc.

TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819133

In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Tango Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
122
−14 vs. Q4 2024
Shares held
107.3M
+6.57M (+6.5%) vs. Q4 2024
Total value
$147.0M
−$164.5M (−52.8%) vs. Q4 2024
New holders
17
42 more added
Sold out
31
39 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 122 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 46 institutionsQ4 2021: 58 institutionsQ1 2022: 72 institutionsQ2 2022: 77 institutionsQ3 2022: 87 institutionsQ4 2022: 82 institutionsQ1 2023: 92 institutionsQ2 2023: 89 institutionsQ3 2023: 100 institutionsQ4 2023: 121 institutionsQ1 2024: 126 institutionsQ2 2024: 120 institutionsQ3 2024: 121 institutionsQ4 2024: 138 institutionsQ1 2025: 122 institutionsQ2 2025: 115 institutionsQ3 2025: 141 institutionsQ4 2025: 170 institutionsQ1 2026: 194 institutionsQ2 2026: 247 institutions
Value heldQ1 2025: $147.0M
Q1 2021: $0Q2 2021: $0Q3 2021: $844.9MQ4 2021: $741.0MQ1 2022: $528.2MQ2 2022: $319.1MQ3 2022: $246.8MQ4 2022: $498.4MQ1 2023: $275.9MQ2 2023: $226.8MQ3 2023: $999.9MQ4 2023: $927.1MQ1 2024: $781.2MQ2 2024: $846.0MQ3 2024: $781.2MQ4 2024: $329.2MQ1 2025: $147.0MQ2 2025: $651.7MQ3 2025: $1.18BQ4 2025: $1.53BQ1 2026: $3.78BQ2 2026: $6.60B
Institutions holding TNGX and their total value by quarter
QuarterHoldersValue
Q2 2026247$6.60B
Q1 2026194$3.78B
Q4 2025170$1.53B
Q3 2025141$1.18B
Q2 2025115$651.7M
Q1 2025122$147.0M
Q4 2024138$329.2M
Q3 2024121$781.2M
Q2 2024120$846.0M
Q1 2024126$781.2M
Q4 2023121$927.1M
Q3 2023100$999.9M
Q2 202389$226.8M
Q1 202392$275.9M
Q4 202282$498.4M
Q3 202287$246.8M
Q2 202277$319.1M
Q1 202272$528.2M
Q4 202158$741.0M
Q3 202146$844.9M
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding TNGX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Jacobs Levy Equity Management, Inc737,955$1.01M0.00%+220,529+42.6%Added
Acadian Asset Management LLC973,309$1.33M0.00%+478,203+96.6%Added
State Street Corp1,144,443$1.57M0.00%−86,756−7.0%Reduced
Geode Capital Management, LLC1,383,437$1.90M0.00%−3,012−0.2%Reduced
Millennium Management LLC1,470,932$2.02M0.00%+1,221,286+489.2%Added
Marshall Wace, LLP1,842,163$2.52M0.00%+1,842,163New
Blue Owl Capital Holdings LP2,121,652$2.91M0.94%+389,500+22.5%Added
Siren, L.L.C.2,565,342$3.51M0.20%−38,555−1.5%Reduced
Bain Capital Life Sciences Investors, LLC2,712,008$3.72M0.55%00.0%Unchanged
Nantahala Capital Management, LLC2,987,983$4.09M0.34%+183,573+6.5%Added
Balyasny Asset Management LLC3,219,571$4.41M0.01%−59,625−1.8%Reduced
T. Rowe Price Investment Management, Inc.3,312,449$4.54M0.00%−33,102−1.0%Reduced
Vanguard Group Inc3,875,545$5.31M0.00%−109,680−2.8%Reduced
BlackRock, Inc.4,032,012$5.52M0.00%−346,491−7.9%Reduced
Farallon Capital Management, L.L.C.4,610,930$6.32M0.03%+610,930+15.3%Added
Gilead Sciences, Inc.4,854,443$6.65M0.56%00.0%Unchanged
Nextech Invest, Ltd.5,533,980$7.58M1.76%+5,533,980New
Boxer Capital Management, LLC10,380,999$14.2M4.28%00.0%Unchanged
EcoR1 Capital, LLC10,630,736$14.6M0.87%00.0%Unchanged
TCG Crossover Management, LLC10,736,000$14.7M2.01%00.0%Unchanged
TRV GP IV, LLC16,859,075$23.1M24.88%00.0%Unchanged
DekaBank Deutsche Girozentrale60,000––00.0%Unchanged
Superstring Capital Management LP0$00.00%−474,955−100.0%Sold out
Wellington Management Group LLP0$00.00%−138,247−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−121,993−100.0%Sold out
PDT Partners, LLC0$00.00%−102,807−100.0%Sold out
Swiss National Bank0$00.00%−94,900−100.0%Sold out
Verition Fund Management LLC0$00.00%−81,045−100.0%Sold out
UBS Asset Management Americas Inc0$00.00%−76,551−100.0%Sold out
Aristides Capital LLC0$00.00%−64,300−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−57,319−100.0%Sold out
Nebula Research & Development LLC0$00.00%−51,924−100.0%Sold out
HRT Financial LP0$00.00%−31,146−100.0%Sold out
Catalina Capital Group, LLC0$00.00%−26,593−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−24,945−100.0%Sold out
Corton Capital Inc.0$00.00%−24,408−100.0%Sold out
MetLife Investment Management0$00.00%−19,631−100.0%Sold out
Sequoia Financial Advisors, LLC0$00.00%−14,631−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−14,544−100.0%Sold out
Arizona State Retirement System0$00.00%−13,976−100.0%Sold out
Bleakley Financial Group, LLC0$00.00%−12,849−100.0%Sold out
Squarepoint Ops LLC0$00.00%−12,843−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−12,307−100.0%Sold out
Janus Henderson Group PLC0$00.00%−11,631−100.0%Sold out
Stonebrook Private Inc.0$00.00%−10,992−100.0%Sold out
KLP Kapitalforvaltning AS0$00.00%−6,300−100.0%Sold out
R Squared Ltd0$00.00%−3,140−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−1,356−100.0%Sold out
Allworth Financial LP0$00.00%−474−100.0%Sold out
Signaturefd, LLC0$00.00%−346−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−330−100.0%Sold out
Rothschild Investment LLC0$00.00%−40−100.0%Sold out
IFP Advisors, Inc0$00.00%0Sold out
Nextech Invest AG––––Not filed
Nuveen Asset Management, LLC––––Not filed